Back to Awarded Treatment Trials


Awarded Trial: 11T-008

Grant ID

11T-008

Illness

bipolar

Primary Drug/Intervention

iradipine

Primary Dosage

10 mg

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Cancelled

Investigator

Perlis

Sample Size

30

Duration of Study Period for Each Subject

28

Outcome Measurements

N/A

Results

Study was cancelled due to low patient recruitment.

Publication

N/A

Link

N/A

PI Name

Roy Perlis

Degree

MD

Center

N/A

Institution

Massachusetts General Hospital

Address

185 Cambridge St.

City or Town

Boston

State or Province

MA

Zip or Postal Code

2114

Country

USA

Email Address

rperlis@partners.org